SPY322.64-7.66 -2.32%
DIA267.58-5.23 -1.92%
IXIC10,632.99-330.65 -3.02%

NeuBase Therapeutics FY19 EPS $(0.45) Down From $(0.01) YoY

NeuBase Therapeutics (NASDAQ:NBSE) reported quarterly losses of $(0.45) per share. This is a 4400 percent decrease over losses of $(0.01) per share from the same period last year.

Benzinga · 01/09/2020 21:15

NeuBase Therapeutics (NASDAQ:NBSE) reported quarterly losses of $(0.45) per share. This is a 4400 percent decrease over losses of $(0.01) per share from the same period last year.